Quarter
Charts

HEALTHSTREAM, INC.

HSTM

CIK 0001095565 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$80M
↑+7.4% +$5Mvs FY2024 (Q4)
Operating Income
$2M
↓-48.7% -$2Mvs FY2024 (Q4)
Net Income
$2M
↓-49.0% -$2Mvs FY2024 (Q4)
Gross Profit
$51M
↑+3.5% +$2Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Poor
22/100
  • Profitability
    0ROIC 4.5% (10% = solid, 20%+ = moat)
  • Liquidity
    23Current Ratio 0.96 (above 1.5 = solid)
  • Leverage
    0Insufficient data
  • Efficiency
    30Asset Turnover 0.59x (1.0+ = capital-efficient)
  • Growth
    41Revenue YoY +7.4% (10% = solid, 25%+ = elite)
  • Margin Trend
    40Op Margin 3.0% · trend -0.6pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project HSTM's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

6%

Trailing 3-yr CAGR was 6.5%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$31.33
Total enterprise IV
$944M
Diluted shares
0.03B
Terminal PV
$677M (72% of total)
Year-5 FCF
$80M
YearProjected FCFDiscounted PV
+1$63M$57M
+2$67M$55M
+3$71M$53M
+4$75M$51M
+5$80M$50M
Terminal$1.09B$677M

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$4M
investment in PP&E
Dividends paid (TTM)
$4M
cash returned to holders
Stock buybacks (TTM)
$30M
share count reduction
Stock-based comp (TTM)
$8M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$520M
everything owned
Stockholders' equity
$354M
shareholder claim
Net debt
$-8M
Net cash position ($8M)

Recent performance · 63 quarters

Revenue↑+7.4% +$5M
$80M
Net Income↓-48.2% -$2M
$3M
Free Cash Flow↑+18.5% +$2M
$13M
Operating Margin↓-3.3pts
3.0%

Drill down

HSTM Sankey

See HEALTHSTREAM, INC.'s revenue flow into every line item of the income statement and balance sheet — every dollar accounted for, with prior-period comparison.

Open Sankey

HSTM Charts

63 quarters of historical line items — Income, Cash Flow, Balance Sheet, plus margins. Click any chart for the trend dialog.

Open Charts

HSTM Key Metrics

EPS, BVPS, FCF/Share, ROE, ROA, ROIC, D/E, Current Ratio, Quick Ratio, Asset Turnover — 10 CFA-grade fundamentals derived from EDGAR data.

Open Key Metrics